Laura Packel1, Carolyn Fahey1, Prosper Njau2,3, Sandra I McCoy1. 1. Department of Epidemiology and Biostatistics, University of California, Berkeley, School of Public Health, Berkeley, CA. 2. Health for a Prosperous Nation, Dar es Salaam, Tanzania. 3. Ministry of Health, Community Development, Gender, Elderly and Children (MoHCDGEC), Dar es Salaam, Tanzania.
Abstract
BACKGROUND: Ambitious targets have been set to end the HIV epidemic by 2030. Such targets assume that tools to end HIV exist and are successfully being deployed across populations, albeit unequally. Implementation science approaches are needed to understand the drivers of disparities and how to bring effective interventions to those most in need. We describe a hybrid implementation science approach, adapting a strategy to facilitate retention and viral suppression (VS) among people living with HIV/AIDS in Tanzania. METHODS/ DESIGN: We used Proctor framework and the multiphase optimization strategy to optimize a cash transfer to improve antiretroviral therapy adherence and VS among people living with HIV/AIDS in Tanzania. This involved 3 trials. The first trial tested the efficacy of cash and food assistance compared with the standard of care in improving antiretroviral therapy adherence among treatment initiators. Cash transfers were superior to the standard of care and noninferior, less expensive, and logistically simpler to implement compared with food. The second trial is dose-finding: identifying the optimal amount of cash for a 20% improvement in VS at 6 months. Before this, components were simplified to maximize reach, align with local policies, and reduce staff time. We assessed implementation science constructs to understand barriers to uptake and sustainability. Trial 3 is a cluster randomized controlled trial, testing the effectiveness of the optimized intervention in multiple settings. DISCUSSION/IMPLICATIONS: Our process illustrates the utility of applying multiple implementation science frameworks to arrive at an optimal implementation strategy to bridge the know-do gap with data to show efficacy and maximum potential for scalability and sustainability.
RCT Entities:
BACKGROUND: Ambitious targets have been set to end the HIV epidemic by 2030. Such targets assume that tools to end HIV exist and are successfully being deployed across populations, albeit unequally. Implementation science approaches are needed to understand the drivers of disparities and how to bring effective interventions to those most in need. We describe a hybrid implementation science approach, adapting a strategy to facilitate retention and viral suppression (VS) among people living with HIV/AIDS in Tanzania. METHODS/ DESIGN: We used Proctor framework and the multiphase optimization strategy to optimize a cash transfer to improve antiretroviral therapy adherence and VS among people living with HIV/AIDS in Tanzania. This involved 3 trials. The first trial tested the efficacy of cash and food assistance compared with the standard of care in improving antiretroviral therapy adherence among treatment initiators. Cash transfers were superior to the standard of care and noninferior, less expensive, and logistically simpler to implement compared with food. The second trial is dose-finding: identifying the optimal amount of cash for a 20% improvement in VS at 6 months. Before this, components were simplified to maximize reach, align with local policies, and reduce staff time. We assessed implementation science constructs to understand barriers to uptake and sustainability. Trial 3 is a cluster randomized controlled trial, testing the effectiveness of the optimized intervention in multiple settings. DISCUSSION/IMPLICATIONS: Our process illustrates the utility of applying multiple implementation science frameworks to arrive at an optimal implementation strategy to bridge the know-do gap with data to show efficacy and maximum potential for scalability and sustainability.
Authors: James H McMahon; Michael R Jordan; Karen Kelley; Silvia Bertagnolio; Steven Y Hong; Christine A Wanke; Sharon R Lewin; Julian H Elliott Journal: Clin Infect Dis Date: 2011-01-18 Impact factor: 9.079
Authors: C Hendricks Brown; Geoffrey Curran; Lawrence A Palinkas; Gregory A Aarons; Kenneth B Wells; Loretta Jones; Linda M Collins; Naihua Duan; Brian S Mittman; Andrea Wallace; Rachel G Tabak; Lori Ducharme; David A Chambers; Gila Neta; Tisha Wiley; John Landsverk; Ken Cheung; Gracelyn Cruden Journal: Annu Rev Public Health Date: 2017-03-20 Impact factor: 21.981
Authors: Enola K Proctor; John Landsverk; Gregory Aarons; David Chambers; Charles Glisson; Brian Mittman Journal: Adm Policy Ment Health Date: 2008-12-23
Authors: Damien de Walque; William H Dow; Rose Nathan; Ramadhani Abdul; Faraji Abilahi; Erick Gong; Zachary Isdahl; Julian Jamison; Boniphace Jullu; Suneeta Krishnan; Albert Majura; Edward Miguel; Jeanne Moncada; Sally Mtenga; Mathew Alexander Mwanyangala; Laura Packel; Julius Schachter; Kizito Shirima; Carol A Medlin Journal: BMJ Open Date: 2012-02-08 Impact factor: 3.006
Authors: Alexsandra Andrawis; James Tapa; Ivo Vlaev; Daniel Read; Kelly Ann Schmidtke; Eric P F Chow; David Lee; Christopher K Fairley; Jason J Ong Journal: Curr HIV/AIDS Rep Date: 2022-08-05 Impact factor: 5.495
Authors: Carolyn A Fahey; Prosper F Njau; Nicole K Kelly; Rashid S Mfaume; Patrick T Bradshaw; William H Dow; Sandra I McCoy Journal: BMJ Glob Health Date: 2021-12